Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 4 Compare versions History 37 Sponsors

House Committee Report — · 154 words Open full page ↗

By: Blanco, et al.

S.B. No. 1098

(Hull)

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

2.8% Unlikely

Why this number

Stage base Passed First Chamber — base rate 22%, measured from TX's completed sessions
Momentum +3 64/100 from the pace of recorded action
Time since last action -22 506 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.